Cdc25B as a steroid receptor coactivator.

Area of Science:

• Molecular Biology
• Cell Biology
• Cancer Research

Background:

• The Cdc25 family of phosphatases traditionally regulates cell cycle progression by activating cyclin-dependent kinases (CDKs).
• Steroid receptors, including estrogen receptor (ER) and androgen receptor (AR), play critical roles in various physiological processes and cancers.

Purpose of the Study:

• To investigate the novel function of Cdc25B as a steroid receptor coactivator.
• To explore the role of Cdc25B in coactivating ER and AR and its implications in neoplasia.

Main Methods:

• Overexpression of Cdc25B in transgenic mammary glands.
• Coexpression of Cdc25B with ER, GR, PR, and AR.
• Assays for ER-dependent reporter gene activity in the presence of estradiol.
• Demonstration of direct interaction between Cdc25B and nuclear receptors.
• Assessment of histone acetyltransferase (HAT) recruitment and activity.
• Cell-free transcription assays.
• Analysis of Cdc25B expression in prostate tumors.

Main Results:

• Cdc25B up-regulates ER-target genes cyclin D1 and Lactoferrin.
• Cdc25B coactivates ER, GR, PR, and AR.
• Cdc25B directly interacts with nuclear receptors, enhances HAT activity, and potentiates transcription.
• Cdc25B is upregulated in high-grade prostate tumors, suggesting a role in hormone-independent progression.

Conclusions:

• Cdc25B possesses a dual function: cell cycle regulation and steroid receptor coactivation.
• Cdc25B-mediated coactivation of steroid receptors, particularly AR, may contribute to cancer development and progression.
• Cdc25B's dual functions suggest a significant role in promoting neoplasia.